[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100406989":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":22,"centralContacts":26,"locations":32,"responsibleParty":47,"collaborators":50,"id":54,"slug":10,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":10,"eligibilityCriteria":58,"healthyVolunteers":59,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":10,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":10,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Stanford University","OTHER",[8,13],{"label":9,"type":10,"description":10,"interventionNames":11},"COVID-19 participants",null,[12],"Biological: Flu shot",{"label":14,"type":10,"description":10,"interventionNames":15},"Control participants",[12],[17],{"type":18,"name":19,"description":20,"armGroupLabels":21,"otherNames":10},"BIOLOGICAL","Flu shot","All participants will receive a single shot of the flu vaccine",[9,14],[23],{"name":24,"affiliation":5,"role":25},"Sayantani Sindher, MD","PRINCIPAL_INVESTIGATOR",[27],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},"SNP Center Inquiry","CONTACT","(650) 521-7237","snpcenterallergy_inquiry@stanford.edu",[33],{"facility":5,"status":34,"city":35,"state":36,"zip":37,"country":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"RECRUITING","Palo Alto","California","94304","United States",{"type":40,"coordinates":41},"Point",[42,43],-122.14302,37.44188,{"lat":43,"lon":42},[46],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},{"type":25,"investigatorFullName":48,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Sayantani B. Sindher","Associate Professor of Medicine",[51],{"name":52,"class":53},"National Institute of Allergy and Infectious Diseases (NIAID)","NIH","100406989",false,"NCT04579588","Understanding Immunity to the Flu Vaccine in COVID-19 Patients","Inclusion Criteria:\n\n* Age 9 through 64 years\n* Diagnosed with COVID-19 at least 2 months prior enrollment\n* Patients with or without obesity, diabetes, chronic fatigue and\u002For long term COVID-19 symptoms\n* Patients without COVID-19 diagnosis for controls\n\nExclusion Criteria:\n\n* Received the influenza vaccine less than 4 months ago\n* Pregnant or lactating\n* Patients with special risks attendant to venipuncture\n* Use of immunomodulatory medications that may impact vaccine immune response per clinician's judgment\n* Contraindication to the flu vaccine\n* Immunodeficiency or autoimmune disease that may impact vaccine immune responses per clinician's judgement",true,"ALL","9 Years","64 Years",{"count":64,"type":65},230,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 9 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.",[69,70,71],"Corona Virus Infection","Flu Vaccine","Immunity","2026-03-16",{"date":74,"type":75},"2026-03-18","ACTUAL",{"date":77,"type":75},"2020-10-29",{"date":79,"type":65},"2028-04",{"name":5,"class":6},1]